<code id='35A4A7AA86'></code><style id='35A4A7AA86'></style>
    • <acronym id='35A4A7AA86'></acronym>
      <center id='35A4A7AA86'><center id='35A4A7AA86'><tfoot id='35A4A7AA86'></tfoot></center><abbr id='35A4A7AA86'><dir id='35A4A7AA86'><tfoot id='35A4A7AA86'></tfoot><noframes id='35A4A7AA86'>

    • <optgroup id='35A4A7AA86'><strike id='35A4A7AA86'><sup id='35A4A7AA86'></sup></strike><code id='35A4A7AA86'></code></optgroup>
        1. <b id='35A4A7AA86'><label id='35A4A7AA86'><select id='35A4A7AA86'><dt id='35A4A7AA86'><span id='35A4A7AA86'></span></dt></select></label></b><u id='35A4A7AA86'></u>
          <i id='35A4A7AA86'><strike id='35A4A7AA86'><tt id='35A4A7AA86'><pre id='35A4A7AA86'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:143
          Adobe

          Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

          The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

          advertisement

          Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In
          Previous article: Senators: Long
          Next article: Alkermes shareholders re

          comprehensive

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Changes to biosimilar regulatory framework must prioritize patients
          Changes to biosimilar regulatory framework must prioritize patients

          JUANMABROMATA/AFPviaGettyImagesBiosimilarsarenolongeranewanduntestedclassofmedicines.Today,theyprovi

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

          AdobeTheFoodandDrugAdministrationsaidMondaythatithasdeepreservationsaboutNurOwn,aninvestigationalALS